RecruitingNot ApplicableNCT05160129

Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder


Sponsor

Icahn School of Medicine at Mount Sinai

Enrollment

20 participants

Start Date

Aug 13, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

Deep brain stimulation (DBS) is an effective treatment for people suffering from severe obsessive-compulsive disorder (OCD) whose symptoms have failed to improve after years and multiple methods of intervention. An effective DBS target for OCD is the anterior limb of the internal capsule (ALIC) brain region. On average 60% of all OCD patients have a clinically significant response to ALIC DBS. However, ALIC DBS may become even more effective with the ability to predict which specific ALIC connections in the brain need to be stimulated for each individual OCD patient. This study therefore investigates personalized stimulation to the ALIC that allows for precise modulation of brain circuits associated with individual OCD symptoms. The study aims to specify the ideal anatomical target for ALIC DBS for maximum therapeutic benefit in each patient.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is refining how deep brain stimulation (DBS) — a procedure where a small device is implanted in the brain to send electrical signals — is targeted and optimized for people with severe, treatment-resistant obsessive-compulsive disorder (OCD). **You may be eligible if...** - You are 18 years of age or older - You have severe OCD that has not improved despite many years of treatment - You have already failed at least three different SSRI antidepressants (e.g., fluoxetine, sertraline), clomipramine, combination medication approaches, and an adequate trial of Cognitive Behavioral Therapy (CBT) - You have already decided (with your treating doctor) to receive DBS surgery for OCD outside of this research study **You may NOT be eligible if...** - You do not meet the FDA humanitarian device criteria for DBS in OCD - You have not tried the required number of medications and therapies first - You have not had at least 5 years of severely disabling OCD Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICESelective focal stimulation of ALIC-pathways

DBS will be applied selectively to different electrode contacts/ segments to evaluate clinical, behavioral, and electrocortical responses of specific pathways within the ALIC.


Locations(1)

Mount Sinai West

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05160129


Related Trials